HEMOSTEMIX INC (HEM.CA) Stock News

TSX-V:HEM - CA4236943060 - Common Stock

0.11 CAD

+0.04 (+46.67%)

Last: 8/29/2025, 7:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

HEM.CA Latest News, Press Relases and Analysis

All

Press Releases

6 months ago - By: Virtual Investor Conferences - Mentions: CGTX AVCN.CA COCP NGEN.CA ...

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

6 months ago - By: Virtual Investor Conferences - Mentions: CGTX AVCN.CA COCP NGEN.CA ...

Life Sciences Investor Forum Agenda Announced for March 13th

3 years ago - By: InvestmentPitch Media and Hemostemix Inc - Mentions: OTC

InvestmentPitch Media Video Discusses Hemostemix and its Hiring of 4 Biotechnologists to Re-Establish Production of ACP-01 in Montreal and Applying for Grants to Fund Up to 75% of 5-Year Expenses

3 years ago - By: InvestmentPitch Media and Hemostemix Inc - Mentions: OTC

InvestmentPitch Media Video Discusses Hemostemix and its $250,000 in Funding from McGill University Health Centre Foundation for Clinical Trial of ACP-01

6 years ago - By: Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions

News Image

IIROC Trading Resumption - HEM

6 years ago - By: Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions

News Image

IIROC Trading Halt - HEM

6 years ago - By: Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions

News Image

IIROC Trading Resumption - HEM

6 years ago - By: Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions

News Image

IIROC Trading Halt - HEM